The identical execution price and date across CEO/CFO/director sales suggest a pre-arranged plan or blackout-window opening rather than reactive selling. At 0.08% of market cap, these volumes are noise. However, the CEO's sale of ~$190K is the largest single insider transaction in the trailing 30 days, monitor for any material 8-K or pipeline update within the next two weeks that might have prompted the timing.
REPL drugs
REPL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 21 $5.22entry
- T+1 · 6mo ago −5.94%α −6.38% · $4.91
- T+5 · 6mo ago +66.48%α +64.63% · $8.69
- T+20 · 5mo ago +113.98%α +113.65% · $11.17
- T+60 · 3mo ago +180.27%α +175.97% · $14.63
Price Chart
How similar events traded
Executive Summary
Three REPL insiders (CEO, CFO, and a director) sold a total of $319K in open-market sales on May 18, 2026, all at $5.08 per share. The CEO's sale of $190K is the largest, and the cluster timing is identical across all three, suggesting a coordinated or programmatic exit rather than opportunistic selling based on fresh negative information.
Key Financial Metrics
Key Facts
- CEO Patel Sushil sold 37,324 shares for $190K
- CFO Hill Emily Luisa sold 7,812 shares for $40K
- Director Astley-Sparke Philip sold 17,657 shares for $90K
- All three trades executed at $5.08 on May 18, 2026
- Total cluster value $319K represents 0.08% of $388M market cap
- No open-market purchases in the cluster, all sales
Financial Impact
$319K total insider sales, below 0.1% of market cap, trivial relative to company size
Risk Factors
- CEO sold the largest dollar amount, insider confidence signal worth tracking
- No insider buying to offset the selling, one-sided signal
- REPL has a 59% bearish analyst consensus, selling could amplify existing negative sentiment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-REPL-1779308220177 |
Track record
32 reports on REPL
9 of 13 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $21.90 Now $21.41 −2.24% settles Feb 12
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $21.78 Now $21.41 −1.70% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $23.28 Now $21.41 −8.03% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $23.28 Now $21.41 −8.03% settles Feb 8
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $22.26 Now $21.41 −3.82% settles Feb 5
- Nov 6, 202610d ago 10-Q/A Neutral 3/10 Entry $22.26 Now $21.41 −3.82% settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Bearish 4/10 Entry $20.69 Now $21.41 −3.48% settles Feb 2
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $20.69 Now $21.41 +3.48% settles Feb 2
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $20.65 Now $21.41 +3.68% settles Feb 1
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $19.49 Now $21.41 +9.85% settles Jan 29
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers